OrsoBio’s experimental oral drug lowered fasting triglyceride levels at four weeks of treatment, hitting the primary efficacy goal in a midstage study of metabolic conditions. | OrsoBio’s experimental ...

The distribution of body fat, and particularly fat accumulated around the abdomen, is a determining factor in the risk of developing metabolic and cardiovascular diseases. However, not all abdominal ...

MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases - A Market Projected to Exceed $120 billion by 2030 ...

A new study suggests that even modest amounts of this carbonated beverage may be associated with higher rates of metabolic ...

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

As dementia and other neurodegenerative diseases become more common worldwide, researchers are searching urgently for ways to ...

Many people may have a dim view of their fat tissue, yet scientists have come to recognize adipose as a necessary and metabolically active organ, carrying out many vital functions within the body. In ...

New Birmingham study is the first to show how tightly linked metabolic and inflammatory improvements are in response to exercise as we age.

For many people, an increase in body weight is often accompanied by rising blood sugar levels, which usually appears without noticeable symptoms. This silent progression leads to a metabolic breakdown ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced a strong global intellectual property portfolio supporting lead ...

Combination of debt and founder’s equity will support the continued expansion of Metabolic, extending access to evidence-based, technology-enabled metabolic care across new communities in Dubai, ...